Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Merck Makes First Round Of Job Cuts
by Lisa M. Jarvis
November 4, 2013
| A version of this story appeared in
Volume 91, Issue 44
After announcing plans last month to shed another 8,500 jobs from its workforce, Merck & Co. began last week to notify employees of their fate. Although Merck has not provided specifics about where cuts are being made, a “warn notice” on the state of Pennsylvania’s Department of Labor website reveals 500 jobs will be lost at the company’s West Point campus. The cuts come as Merck struggles to get new drugs to the market. Last week, Merck announced that third-quarter sales and earnings were down 4% and 7%, respectively, compared with the year-ago period.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter